NVSEF - Novartis beats top-line and bottom-line estimates; raises FY24 core operating income outlook July, 18 2024 01:48 AM Novartis Ag Basel Akt 2024-07-18 01:48:21 ET More on Novartis: Novartis Q2 Earnings Preview: Positive Fundamental Trends Should Continue Novartis: Buy This Blue-Chip Dividend Stock On Sale Now Novartis intends to implement merger squeeze-out of MorphoSys minority shareholders For further details see: Novartis beats top-line and bottom-line estimates; raises FY24 core operating income outlook